Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-237192
Filing Date
2024-10-15
Accepted
2024-10-15 07:03:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d726235d424b3.htm 424B3 16703
2 GRAPHIC g726235g1015031214016.jpg GRAPHIC 3479
  Complete submission text file 0001193125-24-237192.txt   22843
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-276774 | Film No.: 241369223
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)